BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12453866)

  • 1. A case of acute tubular necrosis due to oxaliplatin.
    Pinotti G; Martinelli B
    Ann Oncol; 2002 Dec; 13(12):1951-2. PubMed ID: 12453866
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal toxicity of oxaliplatin.
    Labaye J; Sarret D; Duvic C; Hérody M; Didelot F; Nédélec G; Noël LH
    Nephrol Dial Transplant; 2005 Jun; 20(6):1275-6. PubMed ID: 15827046
    [No Abstract]   [Full Text] [Related]  

  • 3. Oxaliplatin-induced proximal renal tubular acidosis.
    Negro A; Grasselli C; Galli P
    Intern Emerg Med; 2010 Jun; 5(3):267-8. PubMed ID: 19937480
    [No Abstract]   [Full Text] [Related]  

  • 4. Oxaliplatin induced acute tubular necrosis.
    Jain A; Dubashi B; Parameswaran S; Ganesh RN
    Indian J Cancer; 2015; 52(3):363-4. PubMed ID: 26905139
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxaliplatin-related hyperammonaemic encephalopathy in a patient with colon cancer.
    Chang YY; Lin JK; Jiang JK
    Colorectal Dis; 2012 Dec; 14(12):e821. PubMed ID: 22330089
    [No Abstract]   [Full Text] [Related]  

  • 6. A case report of oxaliplatin extravasation.
    Foo KF; Michael M; Toner G; Zalcberg J
    Ann Oncol; 2003 Jun; 14(6):961-2. PubMed ID: 12796037
    [No Abstract]   [Full Text] [Related]  

  • 7. Oxaliplatin-induced renal tubular vacuolization.
    Joybari AY; Sarbaz S; Azadeh P; Mirafsharieh SA; Rahbari A; Farasatinasab M; Mokhtari M
    Ann Pharmacother; 2014 Jun; 48(6):796-800. PubMed ID: 24615628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guillain-Barré syndrome in a patient with metastatic colon cancer receiving oxaliplatin-based chemotherapy.
    Christodoulou C; Anastasopoulos D; Visvikis A; Mellou S; Detsi I; Tsiakalos G; Pateli A; Klouvas G; Papadimitriou A; Skarlos DV
    Anticancer Drugs; 2004 Nov; 15(10):997-9. PubMed ID: 15514570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe anaphylactic reactions to oxaliplatin.
    Tournigand C; Maindrault-Goebel F; Louvet C; de Gramont A; Krulik M
    Eur J Cancer; 1998 Jul; 34(8):1297-8. PubMed ID: 9849497
    [No Abstract]   [Full Text] [Related]  

  • 10. 'Out of blue' Lhermitte's sign: three cases due to low cumulative doses of oxaliplatin.
    Jurado JM; Pajares B; Olmos D; Sevilla I; Alba E
    Ann Oncol; 2008 Dec; 19(12):2093-4. PubMed ID: 18977850
    [No Abstract]   [Full Text] [Related]  

  • 11. Oxaliplatin-related acute disseminated intravascular coagulation syndrome in a patient with metastatic colon cancer.
    Malkhasyan K; Halene S; Lacy J
    Clin Colorectal Cancer; 2015 Mar; 14(1):e9-e12. PubMed ID: 25446051
    [No Abstract]   [Full Text] [Related]  

  • 12. Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case Report.
    Woo HS; Lee KH; Yoon PH; Kim SJ; Park I; Kim YS; Ahn HK; Hong J; Shin DB; Sym SJ
    Cancer Res Treat; 2015 Oct; 47(4):949-53. PubMed ID: 25544580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation recall with oxaliplatin: report of a case and a review of the literature.
    Chan RT; Au GK; Ho JW; Chu KW
    Clin Oncol (R Coll Radiol); 2001; 13(1):55-7. PubMed ID: 11292139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute idiopathic polyneuritis: a potentially fatal neuropathy that is difficult to diagnose in patients receiving oxaliplatin].
    Trabut JB; Brezault C; Chaussade S; Lamarque D
    Gastroenterol Clin Biol; 2007 Feb; 31(2):198-9. PubMed ID: 17347631
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of patients with intestinal cancer. Increased neurotoxicity after oxaliplatin and related liver metastasis].
    Junker A; Kretzschmar A; Böhm U; Tannapfel A; Langenbahn D; Pieck AC; Jaehde U
    Med Monatsschr Pharm; 2004 Oct; 27(10):349-52. PubMed ID: 15527179
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunohemolytic anemia following oxaliplatin administration.
    Garufi C; Vaglio S; Brienza S; Conti L; D'Attino RM; Girelli G; Terzoli E
    Ann Oncol; 2000 Apr; 11(4):497. PubMed ID: 10847475
    [No Abstract]   [Full Text] [Related]  

  • 17. [A case of hypersensitivity reaction to reintroduced-oxaliplatin at the second course of oxaliplatin-based chemotherapy after neoadjuvant chemotherapy for liver metastases from colon cancer].
    Katayose Y; Nakagawa K; Onogawa T; Yoshida H; Motoi F; Naitoh T; Rikiyama T; Egawa S; Unno M
    Gan To Kagaku Ryoho; 2011 Dec; 38(13):2651-3. PubMed ID: 22189236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxaliplatin-induced immune thrombocytopenia in a patient with colon cancer.
    Akdeniz A; Kucukoztas N; Yalcin S; Akcali Z; Altundag O
    Am Surg; 2011 Jan; 77(1):E9. PubMed ID: 21396291
    [No Abstract]   [Full Text] [Related]  

  • 19. Oxaliplatin biotransformation and pharmacokinetics: a pilot study to determine the possible relationship to neurotoxicity.
    Shord SS; Bernard SA; Lindley C; Blodgett A; Mehta V; Churchel MA; Poole M; Pescatore SL; Luo FR; Chaney SG
    Anticancer Res; 2002; 22(4):2301-9. PubMed ID: 12174918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T0 N1 adenocarcinoma of the colon following oxaliplatin-based neoadjuvant chemotherapy.
    Gervaz P; Morel P
    J Surg Oncol; 2008 Jan; 97(1):94-5. PubMed ID: 18085621
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.